Health and Fitness Health and Fitness
Fri, June 3, 2011
[ 04:59 PM ] - Market Wire
Covidien annonce la?obtention de la?autorisation .. robation de la marque europ©enne CE pour sa mail
[ 03:58 PM ] - Market Wire
Ligand and The Medicines Company Agree to Worldwi .. tisol®-Enabled Intravenous Formulation of Clopid
[ 03:20 PM ] - Market Wire
Cardiovascular Systems Announces Filing of Universal Shelf Registration Statement
[ 10:54 AM ] - Market Wire
Five Star Quality Care, Inc. to Present at the Je .. 2011 Global Healthcare Conference on June 9, 2011
[ 10:40 AM ] - Market Wire
Medisafe 1 Technologies Announces Three Medical Device Patent Filings
[ 02:35 AM ] - Market Wire
LifeVantage's Nrf2 Activator Reviewed for Tumor P .. tion and Suppression in New Peer-Reviewed Article
Thu, June 2, 2011
[ 07:10 PM ] - Market Wire
AVEOa?s Ficlatuzumab in Combination with Gefiniti .. with Non-Small Cell Lung Cancer; Phase 1b Data Pr
[ 07:10 PM ] - Market Wire
Covidien meldet US-Zulassung im 510(k)-Verfahren .. -Kennzeichnung fr Parietexa" Optimized Composite-
[ 07:10 PM ] - Market Wire
Schiff Nutrition International Acquires Leading P .. obiotic Brands and Rights to Probiotic Technology
[ 07:10 PM ] - Market Wire
Galectin Therapeutics Announces the Appointment o .. reeman and John Mauldin to the Board of Directors
[ 07:10 PM ] - Market Wire
Continucare Corporation to Present at the Jefferies 2011 Global Healthcare Conference
[ 07:10 PM ] - Market Wire
Final Analysis from AVEO Pharmaceuticalsa? Phase .. ents with Advanced Renal Cell Carcinoma Presented
[ 07:10 PM ] - Market Wire
Abiomed to Present at Jefferies 2011 Global Healthcare Conference
[ 07:10 PM ] - Market Wire
Teva Completes Enrollment in Phase III Multiple S .. Evaluating Glatiramer Acetate Three Times Weekly
[ 04:37 PM ] - Market Wire
Health Management Associates, Inc. Appoints Pascal J. Goldschmidt, M.D. to Board of Directors
[ 05:00 AM ] - Market Wire
Nordion CFO to Present at the Jefferies 2011 Global Healthcare Conference
[ 05:00 AM ] - Market Wire
Nordion Builds North America';s First Food-Only Gamma Irradiator
[ 04:00 AM ] - Market Wire
PROTOX REPORTS FIRST QUARTER 2011 FINANCIAL RESULTS AND ACHIEVEMENTS
[ 04:00 AM ] - Market Wire
MEDIA ADVISORY - Oncolytics Biotech® Inc. to .. ent at Jeffries 2011 Global Healthcare Conference
[ 12:20 AM ] - Market Wire
OncoSec Medical Clinical Adviser Will Present Ele .. m Melanoma Clinical Trial at 2011 ASCO Annual Mee
Wed, June 1, 2011
[ 05:57 PM ] - Market Wire
Amedisys Participates in DecisionHealtha?s Opport .. nities for Accountable Care Organizations Webinar
[ 04:40 PM ] - Market Wire
Covidien to Present at Goldman Sachs Conference
[ 04:40 PM ] - Market Wire
Repligen Concludes Pre-NDA Meeting with FDA for RG1068
[ 04:40 PM ] - Market Wire
ARIAD to Present at the Jefferies 2011 Global Healthcare Conference
[ 04:40 PM ] - Market Wire
LabCorp Enters into Definitive Agreement to Acquire Clearstone Central Laboratories
[ 04:40 PM ] - Market Wire
Abiomed Announces Appointment of Paul G. Thomas to Board of Directors
[ 03:39 PM ] - Market Wire
ImmunoGen, Inc. Announces Webcast of Presentation at Jefferies 2011 Global Healthcare Conference
[ 03:39 PM ] - Market Wire
Inhibitex to Present at the Jefferies 2011 Global Healthcare Conference
[ 03:39 PM ] - Market Wire
Data on IPX066 ADVANCE-PD and APEX-PD Phase III S .. International Congress of Parkinsona?s Disease a
[ 03:39 PM ] - Market Wire
Celldex Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference

Celldex Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference


Published on 2011-06-01 18:40:41 - Market Wire
  Print publication without navigation


NEEDHAM, Mass.--([ BUSINESS WIRE ])--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the Jefferies 2011 Global Healthcare Conference in New York City on Tuesday, June 7, 2011 at 11:00 a.m. ET. A live webcast of the companya™s presentation will be available online on the aPresentationsa page of the aInvestorsa section of the Celldex website at [ http://www.celldextherapeutics.com ] and will be archived for 30 days following the event.

About Celldex Therapeutics, Inc.

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit [ http://www.celldextherapeutics.com ].

Contributing Sources